Dr. Yentz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7500 Challis Rd
Brighton, MI 48116Phone+1 810-263-4000
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 2015 - 2018
- McGaw Medical Center of Northwestern UniversityChief Residency, Internal Medicine, 2014 - 2015
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2011 - 2014
- University of Michigan Medical SchoolClass of 2011
Certifications & Licensure
- MI State Medical License 2015 - 2025
- IL State Medical License 2011 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 32 citationsBiomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.Alexi Vasbinder, YeeAnn Chen, Adrien Procureur, Allison Gradone, Tariq U Azam
JACC. Cardiooncology. 2022-12-01 - 47 citationsIndoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy.Sarah Yentz, David Smith
Biodrugs. 2018-07-06 - 108 citationsSpectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reportsMeng H. Tan, Ravi Iyengar, Kara Mizokami-Stout, Sarah Yentz, Mark MacEachern
Clinical Diabetes and Endocrinology. 2019-01-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: